Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sarin

Showing results (161-170 of 228) with videos related to

Pageof 23
Sort By:
Journal of Virology|October 1, 1973
Properties of noninfectious and transforming viruses released by Murine sarcoma virus-induced hamster tumor cellsA F Gazdar, E Russell, P S Sarma, et al.
Cancer Research|September 1, 1985
Evidence for HTLV-III in T-cells from semen of AIDS patients: expression in primary cell culture, long-term mitogen-stimulated cell cultures, and cocultures with a permissive T-cell lineD Zagury, M Fouchard, R Cheynier, et al.
The Indian Journal of Medical Research|January 1, 1985
Immunoprophylaxis of epidemic non-A non-B hepatitisY K Joshi, S Babu, S Sarin, et al.
Science (New York, N.Y.)|February 21, 1986
Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDSD Zagury, J Bernard, R Leonard, et al.
AJR. American Journal of Roentgenology|April 1, 1994
MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosisJ H Ellis, C Tempany, M S Sarin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1989
Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analoguesS Agrawal, T Ikeuchi, D Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1988
Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virusS Agrawal, J Goodchild, M P Civeira, et al.
European Journal of Vascular Surgery|January 1, 1993
When do vascular surgeons prescribe antiplatelet therapy? Current attitudesS Sarin, S K Shami, T R Cheatle, et al.
Journal of Clinical Immunology|November 1, 1988
Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind studyY Sei, P H Tsang, J P Roboz, et al.
AIDS Research and Human Retroviruses|June 27, 1998
Cross-clade p17 peptide recognition by antisera to HGP-30, a 30-amino acid synthetic peptide antigen from HIV type 1 p17D H Zimmerman, J T Ulrich, C Wright, et al.
Pageof 23

Showing results (161-170 of 228) with videos related to

Sort By:
Pageof 23
Journal of Virology|October 1, 1973
Properties of noninfectious and transforming viruses released by Murine sarcoma virus-induced hamster tumor cellsA F Gazdar, E Russell, P S Sarma, et al.
Cancer Research|September 1, 1985
Evidence for HTLV-III in T-cells from semen of AIDS patients: expression in primary cell culture, long-term mitogen-stimulated cell cultures, and cocultures with a permissive T-cell lineD Zagury, M Fouchard, R Cheynier, et al.
The Indian Journal of Medical Research|January 1, 1985
Immunoprophylaxis of epidemic non-A non-B hepatitisY K Joshi, S Babu, S Sarin, et al.
Science (New York, N.Y.)|February 21, 1986
Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDSD Zagury, J Bernard, R Leonard, et al.
AJR. American Journal of Roentgenology|April 1, 1994
MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosisJ H Ellis, C Tempany, M S Sarin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1989
Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analoguesS Agrawal, T Ikeuchi, D Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1988
Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virusS Agrawal, J Goodchild, M P Civeira, et al.
European Journal of Vascular Surgery|January 1, 1993
When do vascular surgeons prescribe antiplatelet therapy? Current attitudesS Sarin, S K Shami, T R Cheatle, et al.
Journal of Clinical Immunology|November 1, 1988
Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind studyY Sei, P H Tsang, J P Roboz, et al.
AIDS Research and Human Retroviruses|June 27, 1998
Cross-clade p17 peptide recognition by antisera to HGP-30, a 30-amino acid synthetic peptide antigen from HIV type 1 p17D H Zimmerman, J T Ulrich, C Wright, et al.
Pageof 23